Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
They produce 15-21% body weight reduction over 72 weeks
GLP1 receptor agonist effects on lipid and liver profiles in patients with nonalcoholic fatty liver disease: Systematic review and metaanalysis
Lilly is positioning retatrutide as an option for patients seeking more significant weight loss than what can be achieved with the available GLP-1 therapies
Success depends on: Diet quality Physical activity Sleep Medication adherence Dose optimization Underlying medical conditions No medication can replace sustainable lifestyle changes
The injection works by acting on the GLP-1 receptors, which results in decreased appetite and improved satiety
US$ 29.54
US$ 29.89
US$ 21.57
US$ 22.36
